- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03671447
Enhanced Recovery After Intensive Care (ERIC)
Enhanced Recovery After Intensive Care (ERIC) - a Multi-Center Stepped Wedge Cluster-Randomized Controlled Trial
The primary objective of the multi-center stepped-wedge cluster-randomized controlled trial ERIC is to evaluate the effects of a multi-component telemedicine-based intervention delivered by the ICU on the adherence to quality indicators (QI) in intensive care medicine compared to usual care.
Critically ill patients treated on the interventional condition receive daily tele-medical rounds during their ICU stay.
Further secondary objectives are to demonstrate whether the intervention improves patient outcomes 3 and 6 months post ICU discharge, compared to usual care.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Rationale:
Survivors of critical illness frequently develop long-term mental, cognitive, and/or physical impairments summarized as Post Intensive Care Syndrome (PICS). On the national society level, Germany uses 10 core QIs that are evidence-based to improve treatment quality at ICUs.
Objective:
To investigate whether a tele-medical intervention delivered at ICU improves the adherence to established evidence-based QIs in intensive care medicine compared to the adherence at ICUs delivering usual care.
Study design:
ERIC is a stepped-wedge cluster-randomized controlled quality improvement trial with participating ICUs crossing over from usual care to a multifaceted e-health intervention. After the rollout, all recruiting sites will have implemented the experimental intervention for at least 4 months. Follow-up assessments on the patient-level at month 3 and 6 after ICU discharge (index stay) will be conducted in the outpatient or inpatient setting (dependent on the patient's health status).
Study population:
Critically ill patients covered by statutory health insurance treated at participating ICUs in Berlin and Brandenburg, Germany. It is planned to recruit 1431 study patients within 16 months.
Intervention:
Complex telemedicine-based intervention incorporating the use of e-health technologies (virtual care), supported by blended learning of ICU staff prior to the site's crossover.
Comparison:
Intensive care according to current practice.
Endpoints:
Eight co-primary endpoints will be specified. A primary efficacy endpoint is the adherence to a single QI in intensive care medicine (definition according to Kumpf O. et al., 2017) measured on a daily basis, on a patient-level.
Sedation and delirium management in Frankfurt/Oder before and after implementation of the new form of care ERIC - (SeDelFIN) In this sub-project it should be evaluated how the implementation of the evidence-based standard for delirium, analgesia and pain management changes changed after the introduction of the new form of care. For this purpose, the patient files (which are available in paper form) of all patients who were admitted to the intensive care unit of the Department of Anaesthesiology, Intensive Care Medicine and Pain therapy at the Frankfurt/Oder Clinic (study center) were analyzed by Wilma Klink.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Berlin, Germany, 12683
- Unfallkrankenhaus Berlin
-
Berlin, Germany, 10365
- Sana Klinikum Lichtenberg
-
Berlin, Germany, 12203
- Department of Anesthesiolgy and Operative Intensive Care Medicine, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin
-
Berlin, Germany, 13187
- Maria Heimsuchung Caritas Klinik Pankow
-
Berlin, Germany, 13353
- Department of Anesthesiolgy and Operative Intensive Care Medicine CCM/CVK, Charité - Universitätsmedizin Berlin
-
Berlin, Germany, 13589
- Paul Gerhard Diakonie - Evangelisches Waldkrankenhaus Spandau
-
Berlin, Germany, 14129
- Paul Gerhard Diakonie - Evangelisches Krankenhaus Hubertus
-
Berlin, Germany, 14193
- Paul Gerhard Diakonie - Martin-Luther-Krankenhaus
-
Eberswalde, Germany, 16225
- Klinikum Barnim Werner-Forßmann-Krankenhaus
-
Frankfurt (Oder), Germany, 15236
- Klinikum Frankfurt (Oder)
-
Neuruppin, Germany, 16816
- Ruppiner Kliniken
-
Potsdam, Germany, 14467
- Ernst von Bergmann Klinikum - Clinic for Anesthesiology and Operative Intensive Care Medicine
-
Potsdam, Germany, 14467
- Ernst von Bergmann Klinikum - Clinic for Emergency and Internal-Intensive Care Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Patient Level:
Inclusion Criteria:
- Age ≥ 18 years
- Expected to receive treatment in a medical or surgical ICU connected to the project for more than 24 hours
- Coverage by a German statutory health insurance company
- Written informed consent of patient or legal representative
Exclusion Criteria:
• Age < 18 years
Institutional level:
Inclusion Criteria:
- Located in the Berlin/Brandenburg metropolitan region
- Adherence to general legal obligations to participate in the study funded by the German Innovation Fund and participate in the respective contracts.
- Adherence to cluster-randomization
Exclusion Criteria:
• No intensive care beds available
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: ICU usual care
control condition
|
The control condition delivered at ICU is usual care.
|
Experimental: Intervention "ERIC"
intervention condition
|
The experimental complex intervention ERIC consists of daily tele-medicine based rounds at ICU. Tele-ICU is implemented after a blended learning program for ICU staff which will be completed prior to the site's crossover.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
QI 'Daily multiprofessional and interdisciplinary clinical visits with documentation of daily goals'
Time Frame: From enrolment to ICU discharge; Patients assessed for the duration of their ICU stay after enrolment, expected average of 14 days.
|
The adherence [fulfilled yes/no] to this intra-hospital QI is daily assessed on a patient-level
|
From enrolment to ICU discharge; Patients assessed for the duration of their ICU stay after enrolment, expected average of 14 days.
|
QI 'Management of sedation, analgesia, and delirium'
Time Frame: From enrolment to ICU discharge; Patients assessed for the duration of their ICU stay after enrolment, expected average of 14 days.
|
The adherence [fulfilled yes/no] to this intra-hospital QI is daily assessed on a patient-level
|
From enrolment to ICU discharge; Patients assessed for the duration of their ICU stay after enrolment, expected average of 14 days.
|
QI 'Patient-adapted ventilation'
Time Frame: From enrolment to ICU discharge; Patients assessed for the duration of their ICU stay after enrolment, expected average of 14 days.
|
The adherence [fulfilled yes/no] to this intra-hospital QI is daily assessed on a patient-level
|
From enrolment to ICU discharge; Patients assessed for the duration of their ICU stay after enrolment, expected average of 14 days.
|
QI 'Early weaning from invasive ventilation'
Time Frame: From enrolment to ICU discharge; Patients assessed for the duration of their ICU stay after enrolment, expected average of 14 days.
|
The adherence [fulfilled yes/no] to this intra-hospital QI is daily assessed on a patient-level
|
From enrolment to ICU discharge; Patients assessed for the duration of their ICU stay after enrolment, expected average of 14 days.
|
QI 'Measures for infection management'
Time Frame: From enrolment to ICU discharge; Patients assessed for the duration of their ICU stay after enrolment, expected average of 14 days.
|
The adherence [fulfilled yes/no] to this intra-hospital QI is daily assessed on a patient-level
|
From enrolment to ICU discharge; Patients assessed for the duration of their ICU stay after enrolment, expected average of 14 days.
|
QI 'Early enteral nutrition'
Time Frame: From enrolment to ICU discharge; Patients assessed for the duration of their ICU stay after enrolment, expected average of 14 days.
|
The adherence [fulfilled yes/no] to this intra-hospital QI is daily assessed on a patient-level
|
From enrolment to ICU discharge; Patients assessed for the duration of their ICU stay after enrolment, expected average of 14 days.
|
QI 'Documentation of structured patient and family communications'
Time Frame: From enrolment to ICU discharge; Patients assessed for the duration of their ICU stay after enrolment, expected average of 14 days.
|
The adherence [fulfilled yes/no] to this intra-hospital QI is daily assessed on a patient-level
|
From enrolment to ICU discharge; Patients assessed for the duration of their ICU stay after enrolment, expected average of 14 days.
|
QI 'Early mobilization'
Time Frame: From enrolment to ICU discharge; Patients assessed for the duration of their ICU stay after enrolment, expected average of 14 days.
|
The adherence [fulfilled yes/no] to this intra-hospital QI is daily assessed on a patient-level
|
From enrolment to ICU discharge; Patients assessed for the duration of their ICU stay after enrolment, expected average of 14 days.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
All-cause mortality
Time Frame: Up to 6 months following the first study-related ICU admission
|
Number of deaths from any cause within 6 months after enrolment including in-hospital mortality will be recorded (using hospital administrative records, electronic medical records, municipal personal records database and the 3- and 6-month follow-up with surrogates).
|
Up to 6 months following the first study-related ICU admission
|
Mental Health Condition - Depression and Anxiety
Time Frame: 3 and 6 months after ICU discharge
|
The patient-reported symptom burden on anxiety and depression will be assessed by the paper-based Patient-Health-Questionnaire PHQ-4 at month 3 and 6.
Higher total scores indicate higher impairment.
|
3 and 6 months after ICU discharge
|
Mental Health Condition - Post-traumatic Stress
Time Frame: 6 months after ICU discharge
|
Patient-reported symptom burden on post-traumatic stress will be assessed by the paper-based questionnaire Impact of Event Scale revised (IES-R) at month 6.
Higher total scores indicate greater distress.
|
6 months after ICU discharge
|
Cognition - MiniCog
Time Frame: 3 and 6 months after ICU discharge
|
Cognitive functional outcome as assessed by the MiniCog test (2 tests: three-item recall task; clock-drawing task) at month 3 and 6.
Higher scores indicate better cognitive functioning.
|
3 and 6 months after ICU discharge
|
Cognition - Animal Naming Test
Time Frame: 3 and 6 months after ICU discharge
|
Cognitive functional outcome as assessed by the Animal Naming test at month 3 and 6.
Higher scores indicate better cognitive functioning.
|
3 and 6 months after ICU discharge
|
Physical Function - Timed Up & Go Test
Time Frame: 3 and 6 months after ICU discharge
|
Patient's physical function, walking ability and risk of fall as assessed by the Timed Up & Go (TUG) test at month 3 and 6.
Higher scores indicate a higher level of impairment.
|
3 and 6 months after ICU discharge
|
Physical Function - Hand grip strength test
Time Frame: 3 and 6 months after ICU discharge
|
Patient's muscle/ nerve function is assessed by the Hand grip strength (HGS) test (measured with a dynamometer, average strength [in kg] of three trials for the dominant hand) at months 3 and 6.
|
3 and 6 months after ICU discharge
|
Health-related quality of life
Time Frame: 3 and 6 months after ICU discharge
|
Patient's self-reported health-related quality of life as measured by the EuroQol - 5 Dimensions - 5 Level (EQ-5D-5L) Visual Analogue Scale (VAS) and the EQ-5D-5L descriptive system; the EQ-5D-5L VAS is a thermometer-like rating scale ranging from 0 (worst imaginable health state) to 100 (best imaginable health state).
|
3 and 6 months after ICU discharge
|
Organ dysfunction
Time Frame: 3 and 6 months after ICU discharge
|
Number of patients with organ dysfunction as assessed by general practitioner or study personnel/ investigator at month 3 and 6.
|
3 and 6 months after ICU discharge
|
Pulmonary Function - Dyspnea
Time Frame: 6 months after ICU discharge
|
Self-perceived breathlessness as assessed by the Modified British Medical Research Council (mMRC) Dyspnea Scale at month 6. 5-point Likert scale [range 1 to 5] with a higher score indicating higher impairment.
|
6 months after ICU discharge
|
Outpatient ventilation
Time Frame: Up to 6 months after ICU discharge
|
Duration [in days] of mechanical ventilation after discharge from the ICU
|
Up to 6 months after ICU discharge
|
Patient-reported Functioning and Disability (WHO Disability Assessment Schedule).
Time Frame: 6 months after ICU discharge
|
Patient-reported General Disability Score as measured by the WHO Disability Assessment Schedule (WHODAS 2.0) for activity limitation and participation restriction, 12-item short version, self-administered questionnaire.
The raw score is calculated by summing the values for each of the 12 questions.
Higher scores indicate greater disability.
|
6 months after ICU discharge
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Economic - Length of stay at intensive care unit
Time Frame: Up to 6 months
|
Patients will be followed for duration of stay.
The total number of days spent in ICU will be assessed (inclusive of index ICU stay).
|
Up to 6 months
|
Economic - Length of hospital stay
Time Frame: Up to 6 months
|
Patients will be followed for duration of hospital stay.
The total number of days spent in a hospital will be assessed (inclusive of index ICU stay and index hospitalization).
|
Up to 6 months
|
Economic - Return to work
Time Frame: 3 and 6 months after ICU discharge
|
Employment status at 3 months and 6 months after hospital discharge (including e.g. return to work, change in duties or change in effectiveness) at 3 and 6 months.
|
3 and 6 months after ICU discharge
|
Economic - Cost-effectiveness
Time Frame: 3 and 6 months after ICU discharge
|
Health-related costs for standard care and supportive care will be estimated in Euros per patient per months.
Data source will be GPs, hospital-electronic health records and health insurance data as well as publicly available data sources from the German reimbursement system.
|
3 and 6 months after ICU discharge
|
Collaborators and Investigators
Collaborators
Investigators
- Study Director: Claudia Spies, MD, Prof., Department of Anesthesiolgy and Operative Intensive Care Medicine CCM/CVK, Charité - Universitätsmedizin Berlin
Publications and helpful links
General Publications
- Kumpf O, Braun JP, Brinkmann A, Bause H, Bellgardt M, Bloos F, Dubb R, Greim C, Kaltwasser A, Marx G, Riessen R, Spies C, Weimann J, Wobker G, Muhl E, Waydhas C. Quality indicators in intensive care medicine for Germany - third edition 2017. Ger Med Sci. 2017 Aug 1;15:Doc10. doi: 10.3205/000251. eCollection 2017.
- Kastrup M, Tittmann B, Sawatzki T, Gersch M, Vogt C, Rosenthal M, Rosseau S, Spies C. Transition from in-hospital ventilation to home ventilation: process description and quality indicators. Ger Med Sci. 2017 Dec 19;15:Doc18. doi: 10.3205/000259. eCollection 2017.
- Adrion C, Weiss B, Paul N, Berger E, Busse R, Marschall U, Caumanns J, Rosseau S, Mansmann U, Spies C; ERIC study group. Enhanced Recovery after Intensive Care (ERIC): study protocol for a German stepped wedge cluster randomised controlled trial to evaluate the effectiveness of a critical care telehealth program on process quality and functional outcomes. BMJ Open. 2020 Sep 25;10(9):e036096. doi: 10.1136/bmjopen-2019-036096.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ERIC
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Critical Illness
-
Duke UniversityNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes...CompletedNeonatal Critical Illness | Pediatric Critical IllnessUnited States
-
Yale UniversityNational Institute on Aging (NIA)RecruitingCritical Illness | Illness, CriticalUnited States
-
McMaster UniversityLondon Health Sciences Centre; McMaster Children's Hospital; Canadian Critical...CompletedPediatric Critical IllnessCanada
-
Boston Children's HospitalCompleted
-
St Helens & Knowsley Teaching Hospitals NHS TrustManchester University NHS Foundation TrustCompleted
-
Sándor BeniczkyUniversity of Aarhus; Danish Council for Independent Research; Søster og Verner...CompletedCritical Illness Myopathy | Myopathy Critical IllnessDenmark
-
Hospital de Clinicas de Porto AlegreUnknownCritical Illness PolyneuropathiesBrazil
-
Peking Union Medical College HospitalBaxter Healthcare CorporationUnknownNutrition Therapy for Critical Illness
-
Assistance Publique - Hôpitaux de ParisRecruitingCritical Illness Related Corticosteroids InsufficiencyFrance
-
Yuzuncu Yıl UniversityKahramanmaras Sutcu Imam University; Izmir Ataturk Training and Research HospitalCompleted
Clinical Trials on ICU Usual Care
-
University of PittsburghCompletedDepression | AnxietyUnited States
-
University of WashingtonTerminated
-
Wake Forest University Health SciencesNational Institute on Aging (NIA)RecruitingCritical Illness | Cognitive Impairment | Dementia | Cognitive Impairment, Mild | Post ICU SyndromeUnited States
-
University of NebraskaCompletedMobile Applications | Critical Care | FamilyUnited States
-
University Hospital of CologneAlbert Einstein College of Medicine; Monash University; The Alfred; Johann Wolfgang... and other collaboratorsNot yet recruiting
-
University of GöttingenUniversity Medical Center GoettingenUnknownSystemic Lupus Erythematosus | Vasculitis | MyositisGermany
-
Khon Kaen UniversityRecruiting
-
Landspitali University HospitalUniversity of IcelandCompleted
-
University Hospital, Clermont-FerrandCompleted